NCT00563979|Completed
Enhancement of Macular Pigment Density by Oral Lutein Supplementation
EMPOLS
Loading search results
EMPOLS
Sponsor study identifier
interventional
80
1 country
1
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)The primary objective of EMPOLS is an increase in macular pigment density (MPD) and contrast sensitivity (CS) after six months supplementation of oral non-compound ester Lutein 10 mg daily, contained in VitaluxPlus®.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
November 26, 2007
Actual (reported)November 27, 2007
Actual (reported)December 2009
Actual (reported)December 2009
Actual (reported)Macular pigment density
6 months
contrast sensitivity
6 months
VitaluxPlus®
Omega 3
1 tablet daily
1 tablet daily
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Klinik und Poliklinik für Augenheilkunde, University Bern
Bern, Switzerland
Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5.
Wolf-Schnurrbusch UE, Zinkernagel MS, Munk MR, Ebneter A, Wolf S. Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids. Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8069-74. doi: 10.1167/iovs.15-17586.
Sebastian Wolf, MD
University of Bern
Ute Wolf-Schnurrbusch, MD
University of Bern
80 participants (actual enrollment reported by the registry).
First Submitted
November 26, 2007
First Posted
November 27, 2007
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2009
Actual (reported)Last Updated
June 12, 2015
Record last verified: 2015-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: